세계의 폐기능 검사 시스템 시장(제품 유형별, 검사 유형별, 용도별, 최종 용도별, 지역별) : 동향 분석, 경쟁 상황, 예측(2019-2030년)

Global Pulmonary Function Testing (PFT) Systems Market to Reach USD 5.7 Billion by 2030

Global Pulmonary Function Testing (PFT) Systems Market is booming primarily due to rapidly growing geriatric population with rising respiratory diseases and heightened awareness about the benefits of early detection.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Pulmonary Function Testing (PFT) Systems Market size by value at USD 3.4 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pulmonary Function Testing (PFT) Systems Market size to expand at a CAGR of 6.40% reaching a value of USD 5.7 billion by 2030. The Pulmonary Function Testing (PFT) Systems Market across the regions is propelled by the escalating prevalence of respiratory diseases, the growing demand for accurate diagnostic tools, and advancements in spirometry technology. Pulmonary function, a critical aspect of respiratory health, involves the efficient exchange of oxygen and carbon dioxide. PFT systems play a crucial role in assessing lung function by measuring lung volume, capacity, flow rates, and gas exchange. The increasing incidence of respiratory disorders, such as asthma, pneumonia, lung cancer, and chronic obstructive pulmonary disease (COPD), is fueling the demand for PFT systems. Moreover, factors like air pollution, smoking, and infectious diseases are further contributing to the growth of Global PFT Systems Market.

North America Dominates Global PFT Systems Market

Robust healthcare infrastructure and an increasing focus on patient care have made North America the leading region market in Global Pulmonary Function Testing (PFT) Systems Market. The region's aging population and the rising prevalence of respiratory ailments necessitate accurate and timely diagnosis. PFT systems, especially portable devices, are gaining traction in various healthcare settings, from hospitals to clinics. As healthcare providers strive to improve patient outcomes, the demand for advanced PFT technologies is expected to fuel market growth in North America.

Impact of Escalating Geopolitical Tensions on Global Pulmonary Function Testing (PFT) Systems Market

Intensifying geopolitical tensions could have a multifaceted impact on Global Pulmonary Function Testing (PFT) Systems Market. Trade disruptions, sanctions, and political instability can interrupt the supply chain for PFT systems, potentially restricting access to essential components and increasing production costs. Additionally, the healthcare infrastructure in impacted areas may suffer, leading to decreased demand for advanced medical equipment, such as PFT systems. As governments redirect resources to address geopolitical tensions, healthcare expenditures may be reduced, which could hinder the uptake of PFT systems, particularly in regions facing political instability.

Competitive Landscape

Global Pulmonary Function Testing (PFT) Systems Market is highly fragmented, with numerous players serving the market. Key players dominating Global Pulmonary Function Testing (PFT) Systems Market include Vyaire Medical, Geratherm Medical, Vitalograph, Pulsicar, CareFusion, Chest Medical, Medtronic, Omron Healthcare, Philips Respironics, Mindray, Nikkiso Medical, and Schiller. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Global Pulmonary Function Testing (PFT) Systems Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pulmonary Function Testing (PFT) Systems Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Pulmonary Function Testing (PFT) Systems Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Rising Prevalence of Respiratory Diseases
    • 3.2.1.2. Aging Population
    • 3.2.1.3. Increased Awareness and Early Detection
  • 3.2.2. Restraints
    • 3.2.2.1. High Cost of PFT Systems
    • 3.2.2.2. Complex Operation and Interpretation
  • 3.2.3. Opportunities
    • 3.2.3.1. Government Initiatives and Healthcare Reforms
    • 3.2.3.2. Growing Healthcare Infrastructure
  • 3.2.4. Challenges
    • 3.2.4.1. Lack of Standardization
    • 3.2.4.2. Patient Factors
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Pulmonary Function Testing (PFT) Systems Market: Marketing Strategies

5. Global Pulmonary Function Testing (PFT) Systems Market Overview

• 5.1. Market Size & Forecast, 2019-2030
  • 5.1.1. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Handheld
    • 5.2.1.2. Tabletop
  • 5.2.2. By Test Type
    • 5.2.2.1. Spirometry
    • 5.2.2.2. Lung Volume Test
    • 5.2.2.3. Gas Diffusion Test
    • 5.2.2.4. Exercise Stress Test
    • 5.2.2.5. High Altitude Simulation Testing
    • 5.2.2.6. Others
  • 5.2.3. By Application
    • 5.2.3.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 5.2.3.2. Asthma
    • 5.2.3.3. Chronic Shortness of Breath
    • 5.2.3.4. Pulmonary Fibrosis
    • 5.2.3.5. Others
  • 5.2.4. By End Use
    • 5.2.4.1. Hospitals & Clinics
    • 5.2.4.2. Diagnostic Centers
    • 5.2.4.3. Homecare Settings
    • 5.2.4.4. Others
  • 5.2.5. By Region
    • 5.2.5.1. North America
    • 5.2.5.2. Europe
    • 5.2.5.3. Asia Pacific (APAC)
    • 5.2.5.4. Latin America (LATAM)
    • 5.2.5.5. Middle East and Africa (MEA)

6. North America Pulmonary Function Testing (PFT) Systems Market

• 6.1. Market Size & Forecast, 2019-2030
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Test Type
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
    • 6.2.5.1. United States
    • 6.2.5.1.1. By Product
    • 6.2.5.1.2. By Test Type
    • 6.2.5.1.3. By Application
    • 6.2.5.1.4. By End Use
    • 6.2.5.2. Canada
    • 6.2.5.2.1. By Product
    • 6.2.5.2.2. By Test Type
    • 6.2.5.2.3. By Application
    • 6.2.5.2.4. By End Use

7. Europe Pulmonary Function Testing (PFT) Systems Market

• 7.1. Market Size & Forecast, 2019-2030
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Test Type
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
    • 7.2.5.1. Germany
    • 7.2.5.1.1. By Product
    • 7.2.5.1.2. By Test Type
    • 7.2.5.1.3. By Application
    • 7.2.5.1.4. By End Use
    • 7.2.5.2. United Kingdom
    • 7.2.5.2.1. By Product
    • 7.2.5.2.2. By Test Type
    • 7.2.5.2.3. By Application
    • 7.2.5.2.4. By End Use
    • 7.2.5.3. Italy
    • 7.2.5.3.1. By Product
    • 7.2.5.3.2. By Test Type
    • 7.2.5.3.3. By Application
    • 7.2.5.3.4. By End Use
    • 7.2.5.4. France
    • 7.2.5.4.1. By Product
    • 7.2.5.4.2. By Test Type
    • 7.2.5.4.3. By Application
    • 7.2.5.4.4. By End Use
    • 7.2.5.5. Spain
    • 7.2.5.5.1. By Product
    • 7.2.5.5.2. By Test Type
    • 7.2.5.5.3. By Application
    • 7.2.5.5.4. By End Use
    • 7.2.5.6. Belgium
    • 7.2.5.6.1. By Product
    • 7.2.5.6.2. By Test Type
    • 7.2.5.6.3. By Application
    • 7.2.5.6.4. By End Use
    • 7.2.5.7. Russia
    • 7.2.5.7.1. By Product
    • 7.2.5.7.2. By Test Type
    • 7.2.5.7.3. By Application
    • 7.2.5.7.4. By End Use
    • 7.2.5.8. The Netherlands
    • 7.2.5.8.1. By Product
    • 7.2.5.8.2. By Test Type
    • 7.2.5.8.3. By Application
    • 7.2.5.8.4. By End Use
    • 7.2.5.9. Rest of Europe
    • 7.2.5.9.1. By Product
    • 7.2.5.9.2. By Test Type
    • 7.2.5.9.3. By Application
    • 7.2.5.9.4. By End Use

8. Asia Pacific Pulmonary Function Testing (PFT) Systems Market

• 8.1. Market Size & Forecast, 2019-2030
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Test Type
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
    • 8.2.5.1. China
    • 8.2.5.1.1. By Product
    • 8.2.5.1.2. By Test Type
    • 8.2.5.1.3. By Application
    • 8.2.5.1.4. By End Use
    • 8.2.5.2. India
    • 8.2.5.2.1. By Product
    • 8.2.5.2.2. By Test Type
    • 8.2.5.2.3. By Application
    • 8.2.5.2.4. By End Use
    • 8.2.5.3. Japan
    • 8.2.5.3.1. By Product
    • 8.2.5.3.2. By Test Type
    • 8.2.5.3.3. By Application
    • 8.2.5.3.4. By End Use
    • 8.2.5.4. South Korea
    • 8.2.5.4.1. By Product
    • 8.2.5.4.2. By Test Type
    • 8.2.5.4.3. By Application
    • 8.2.5.4.4. By End Use
    • 8.2.5.5. Australia & New Zealand
    • 8.2.5.5.1. By Product
    • 8.2.5.5.2. By Test Type
    • 8.2.5.5.3. By Application
    • 8.2.5.5.4. By End Use
    • 8.2.5.6. Indonesia
    • 8.2.5.6.1. By Product
    • 8.2.5.6.2. By Test Type
    • 8.2.5.6.3. By Application
    • 8.2.5.6.4. By End Use
    • 8.2.5.7. Malaysia
    • 8.2.5.7.1. By Product
    • 8.2.5.7.2. By Test Type
    • 8.2.5.7.3. By Application
    • 8.2.5.7.4. By End Use
    • 8.2.5.8. Singapore
    • 8.2.5.8.1. By Product
    • 8.2.5.8.2. By Test Type
    • 8.2.5.8.3. By Application
    • 8.2.5.8.4. By End Use
    • 8.2.5.9. Vietnam
    • 8.2.5.9.1. By Product
    • 8.2.5.9.2. By Test Type
    • 8.2.5.9.3. By Application
    • 8.2.5.9.4. By End Use
    • 8.2.5.10. Rest of APAC
    • 8.2.5.10.1. By Product
    • 8.2.5.10.2. By Test Type
    • 8.2.5.10.3. By Application
    • 8.2.5.10.4. By End Use

9. Latin America Pulmonary Function Testing (PFT) Systems Market

• 9.1. Market Size & Forecast, 2019-2030
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Test Type
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
    • 9.2.5.1. Brazil
    • 9.2.5.1.1. By Product
    • 9.2.5.1.2. By Test Type
    • 9.2.5.1.3. By Application
    • 9.2.5.1.4. By End Use
    • 9.2.5.2. Mexico
    • 9.2.5.2.1. By Product
    • 9.2.5.2.2. By Test Type
    • 9.2.5.2.3. By Application
    • 9.2.5.2.4. By End Use
    • 9.2.5.3. Argentina
    • 9.2.5.3.1. By Product
    • 9.2.5.3.2. By Test Type
    • 9.2.5.3.3. By Application
    • 9.2.5.3.4. By End Use
    • 9.2.5.4. Peru
    • 9.2.5.4.1. By Product
    • 9.2.5.4.2. By Test Type
    • 9.2.5.4.3. By Application
    • 9.2.5.4.4. By End Use
    • 9.2.5.5. Rest of LATAM
    • 9.2.5.5.1. By Product
    • 9.2.5.5.2. By Test Type
    • 9.2.5.5.3. By Application
    • 9.2.5.5.4. By End Use

10. Middle East & Africa Pulmonary Function Testing (PFT) Systems Market

• 10.1. Market Size & Forecast, 2019-2030
  • 10.1.1. By Value (USD Billion)
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Test Type
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
    • 10.2.5.1. Saudi Arabia
    • 10.2.5.1.1. By Product
    • 10.2.5.1.2. By Test Type
    • 10.2.5.1.3. By Application
    • 10.2.5.1.4. By End Use
    • 10.2.5.2. UAE
    • 10.2.5.2.1. By Product
    • 10.2.5.2.2. By Test Type
    • 10.2.5.2.3. By Application
    • 10.2.5.2.4. By End Use
    • 10.2.5.3. Qatar
    • 10.2.5.3.1. By Product
    • 10.2.5.3.2. By Test Type
    • 10.2.5.3.3. By Application
    • 10.2.5.3.4. By End Use
    • 10.2.5.4. Kuwait
    • 10.2.5.4.1. By Product
    • 10.2.5.4.2. By Test Type
    • 10.2.5.4.3. By Application
    • 10.2.5.4.4. By End Use
    • 10.2.5.5. South Africa
    • 10.2.5.5.1. By Product
    • 10.2.5.5.2. By Test Type
    • 10.2.5.5.3. By Application
    • 10.2.5.5.4. By End Use
    • 10.2.5.6. Nigeria
    • 10.2.5.6.1. By Product
    • 10.2.5.6.2. By Test Type
    • 10.2.5.6.3. By Application
    • 10.2.5.6.4. By End Use
    • 10.2.5.7. Algeria
    • 10.2.5.7.1. By Product
    • 10.2.5.7.2. By Test Type
    • 10.2.5.7.3. By Application
    • 10.2.5.7.4. By End Use
    • 10.2.5.8. Rest of MEA
    • 10.2.5.8.1. By Product
    • 10.2.5.8.2. By Test Type
    • 10.2.5.8.3. By Application
    • 10.2.5.8.4. By End Use

11. Competitive Landscape

• 11.1. List of Key Players and Their Products
• 11.2. Global Pulmonary Function Testing (PFT) Systems Company Market Share Analysis, 2023
• 11.3. Competitive Benchmarking, By Operating Parameters
• 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Pulmonary Function Testing (PFT) Systems Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 13.1. Vyaire Medical
• 13.2. Geratherm Medical
• 13.3. Vitalograph
• 13.4. Pulsicar
• 13.5. CareFusion
• 13.6. Chest Medical
• 13.7. Medtronic
• 13.8. Omron Healthcare
• 13.9. Philips Respironics
• 13.10. Mindray
• 13.11. Nikkiso Medical
• 13.12. Schiller
• 13.13. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

• 15.1. Qualitative Research
  • 15.1.1. Primary & Secondary Research
• 15.2. Quantitative Research
• 15.3. Market Breakdown & Data Triangulation
  • 15.3.1. Secondary Research
  • 15.3.2. Primary Research
• 15.4. Breakdown of Primary Research Respondents, By Region
• 15.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable